Article Details
Retrieved on: 2017-12-14 20:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>CytRx logo <b>Vanguard Group</b> Inc. boosted its holdings in CytRx Co. (NASDAQ:CYTR) by 53.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,823,123 shares of the biotechnology company's stock after purchasing an ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here